Expand BHST Menu
BHST MENU

Bioharvest Sciences (BHST) closed at $1.51 on November 13, 2026, down 7.7% from the previous close, on volume of 9,278 shares (30-day average 25,969).

Key numbers
  • Last close: $1.51 (November 13, 2026)
  • 52-week range: $1.37 to $8.30
  • Market value: $34.1 million

Data as of November 13, 2026.

BHST Stock Summary and Trading Ideas (Bioharvest Sciences | NASDAQ:BHST)

Bioharvest Sciences (BHST) Frequently Asked Questions

What does Bioharvest Sciences do?

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.

What symbol and exchange does Bioharvest Sciences shares trade?

Bioharvest Sciences trades on the NASDAQ stock market under the symbol BHST.

What is Bioharvest Sciences stock price doing today?

As of November 13, 2026, BHST stock price declined to $1.50 with 9,278 million shares trading.

What is Bioharvest Sciences's Beta?

BHST has a beta of 1.97, meaning it tends to be more sensitive to market movements. BHST has a correlation of 0.12 to the broad based SPY ETF.

How much is Bioharvest Sciences worth?

BHST has a market cap of $34.09 million. This is considered a Sub-Micro Cap stock.

How much money does Bioharvest Sciences make?

Last quarter Bioharvest Sciences reported $8 million in Revenue and -$.15 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.01.

Is Bioharvest Sciences (BHST) a good investment?

BHST has underperformed the market in the last year with a price return of -79.4% while the SPY ETF gained +13.4%. BHST has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.3% and -9.3%, respectively, while the SPY returned -2.8% and -0.2%, respectively.

What are the support and resistance levels for Bioharvest Sciences (BHST)?

BHST support price is $1.52 and resistance is $1.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BHST shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes